In 2011, researchers used imaging techniques to investigate brain microbleeds in patients with dementia and highlighted how lobar microbleeds could be used as a marker for amyloid pathology and for predicting mortality. New guidelines on the inclusion and exclusion of participants with microbleeds in anti-amyloid clinical trials were also published.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
ANKS1A regulates LDL receptor-related protein 1 (LRP1)-mediated cerebrovascular clearance in brain endothelial cells
Nature Communications Open Access 20 December 2023
-
Fatal iatrogenic cerebral β-amyloid-related arteritis in a woman treated with lecanemab for Alzheimer’s disease
Nature Communications Open Access 12 December 2023
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cordonnier, C. & van der Flier, W. M. Brain microbleeds and Alzheimer's disease: innocent observation or key player? Brain 134, 335–344 (2011).
Henneman, W. J. et al. MRI biomarkers of vascular damage and atrophy predicting mortality in a memory clinic population. Stroke 40, 492–498 (2009).
Yates, P. A. et al. Cerebral microhemorrhage and brain β-amyloid in aging and Alzheimer disease. Neurology 77, 48–54 (2011).
Goos, J. D. C. et al. Microbleeds relate to altered amyloid-β metabolism in Alzheimer disease. Neurobiol. Aging http://dx.doi.org/10.1016/j.neurobiolaging.2011.10.026.
Altmann–Schneider, I. et al. Cerebral microbleeds are predictive of mortality in the elderly. Stroke 42, 638–644 (2011).
Sperling, R. A. et al. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement. 7, 367–385 (2011).
Goos, J. D. C. et al. Clinical relevance of improved microbleed detection by susceptibility-weighted magnetic resonance imaging. Stroke 42, 1894–1900 (2011).
De Reuck, J. et al. Comparison of 7.0-T T2*-magnetic resonance imaging of cerebral bleeds in post-mortem brain sections of Alzheimer patients with their neuropathological correlates. Cerebrovasc. Dis. 31, 511–517 (2011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Scheltens, P., Goos, J. Microbleeds in dementia—singing a different ARIA. Nat Rev Neurol 8, 68–70 (2012). https://doi.org/10.1038/nrneurol.2011.222
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2011.222
This article is cited by
-
ANKS1A regulates LDL receptor-related protein 1 (LRP1)-mediated cerebrovascular clearance in brain endothelial cells
Nature Communications (2023)
-
Fatal iatrogenic cerebral β-amyloid-related arteritis in a woman treated with lecanemab for Alzheimer’s disease
Nature Communications (2023)
-
Reconstruction of the human blood–brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes
Nature Medicine (2020)
-
Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics
Nature Reviews Neuroscience (2018)
